Gaithersburg

Per the City of Gaithersburg:

At their meeting on Monday, January 3, 2022, the Mayor & City Council conducted a public hearing and then enacted emergency legislation to limit residential rent increases due to the impact of COVID-19. By a vote of 3 to 2, the elected officials amended Chapter 13 of the City Code, “Landlord-Tenant Relations,” to prohibit residential rent increases in excess of Montgomery County’s Voluntary Rent Guideline & prohibit notices of residential rent increase in excess of Montgomery County’s Voluntary Rent Guideline prior to May 15, 2022.


Education

Earlier today in a media briefing, MCPS informed the public that it will be sorting schools into three categories– green, yellow, and red.

The categories will identify whether individual schools are below the 5% threshold (5% of the population of students and staff testing positive for Covid-19 in a 14 day period).


Business

GAITHERSBURG, Md., Dec. 31, 2021 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that it has completed submission of the final data package, including the complete chemistry, manufacturing and controls module, to fulfill the prerequisites for emergency use authorization (EUA) application request to the U.S. Food and Drug Administration (FDA) for NVX-CoV2373, the company’s recombinant nanoparticle protein-based COVID-19 vaccine with Matrix-M™ adjuvant. Novavax expects to submit a request for EUA for the vaccine in the U.S. in one month in accordance with guidance from the FDA regarding submission of all EUA vaccines.

“Novavax is committed to delivering our protein-based vaccine in the United States, where the COVID-19 pandemic continues to evolve with the emergence of new variants, ongoing need to ensure primary vaccination for the eligible population, and need for boosting,” said Stanley C. Erck, President and Chief Executive Officer, Novavax. “We thank the U.S. Government for its ongoing support of our COVID-19 vaccine program, as well as our clinical trial participants and those who have supported the development and manufacturing of our vaccine.”


View More Stories